Full Press Release Details
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease.
BIIB
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
Key Takeaway: FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease